Pro-Cure Therapeutics

About:

Pro-Cure Therapeutics is focused on developing drugs targeted against cancer stem cells.

Top Investors: Maven Capital Partners, SMH Venture Finance Limited, Yorkshire Cancer Research, White Rose Technology Seedcorn Fund

Description:

Pro-Cure Therapeutics Limited is focused on developing drugs targeted against cancer stem cells. The company has identified targets for new classes of cancer drugs that may fundamentally change the management of cancer. They are developing a pipeline of therapeutic candidates against these targets, starting in prostate cancer and then expanding into other tumour types.